Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ 9,178,523	$ (6,911,752)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Accretion of investments	(350,049)	(92,439)
Realized investment gains, net	(37,470)	(716,300)
Change in fair value of equity securities	(12,020,406)	8,645,474
Unrealized trading losses included in income	7,301	0
Amortization of cost of insurance acquired	158,954	165,314
Provision for deferred income taxes	2,387,424	(1,798,119)
Depreciation and depletion	462,855	174,692
Stock-based compensation	299,314	674,390
Charges for mortality and administration of universal life and annuity products	(1,374,829)	(1,448,416)
Interest credited to account balances	901,542	921,074
Change in accrued investment income	280,803	310,385
Change in reinsurance receivables	99,789	368,886
Change in policy liabilities and accruals	(1,219,854)	(1,431,856)
Change in income taxes receivable (payable)	45,205	(122,733)
Change in other assets and liabilities, net	(835,180)	3,257,935
Net cash provided by (used in) operating activities	(2,016,078)	1,996,535
Proceeds from investments sold and matured:
Fixed maturities available for sale	5,000,000	20,833
Equity securities	3,519,729	958,779
Trading securities	102,699	0
Mortgage loans	209,928	984,587
Real estate	722,925	2,046,096
Notes receivable	421,847	66,622
Policy loans	247,513	280,253
Short-term investments	15,750,000	9,740,815
Total proceeds from investments sold and matured	25,974,641	14,097,985
Cost of investments acquired:
Equity securities	(3,107,915)	(1,393,053)
Mortgage loans	(599,189)	0
Real estate	(545,180)	(1,375,010)
Notes receivable	(800,000)	(1,478,100)
Policy loans	(224,197)	(208,423)
Short-term investments	0	(9,701,297)
Total cost of investments acquired	(5,276,481)	(14,155,883)
Net cash provided by (used in) investing activities	20,698,160	(57,898)
Cash flows from financing activities:
Policyholder contract deposits	1,046,208	1,110,855
Policyholder contract withdrawals	(978,348)	(956,744)
Payments of principal on notes payable/line of credit	(19,000,000)	(19,000,000)
Purchase of treasury stock	(108,914)	(100,228)
Net cash used in financing activities	(19,041,054)	(18,946,117)
Net decrease in cash and cash equivalents	(358,972)	(17,007,480)
Cash and cash equivalents at beginning of period	41,185,196	45,290,385
Cash and cash equivalents at end of period	$ 40,826,224	$ 28,282,905